A Retrospect on Clinical Trials and Current Status of Schedule Y in India

Arthropod-borne viruses (arboviruses) are global pathogens circulating endemically with local explosive outbreaks and constant encroachment into new locations. Few vaccines against arboviruses exist; most for humans are in development or clinical trials. Insect-specific viruses (ISVs) offer a unique platform for expression of arbovirus proteins, through the creation of ISV/arbovirus chimeras. Studies have shown promising results of these vaccines with several advantages over their wild-type counterparts. In this review, we discuss the current status of these potential vaccines using ISVs.

Download Full-text

Childhood Brain Tumors: Current Status of Clinical Trials in Newly Diagnosed and Recurrent Disease

Pediatric Clinics of North America ◽

10.1016/s0031-3955(16)34829-5 ◽

1985 ◽

Vol 32 (3) ◽

pp. 633-651 ◽

Cited By ~ 43

Author(s):

Jeffrey C. Allen

Keyword(s):

Clinical Trials ◽

Brain Tumors ◽

Recurrent Disease ◽

Current Status ◽

Newly Diagnosed ◽

Childhood Brain Tumors

Download Full-text

Current Status of Clinical Trials on Drugs and GCP in China

Drug Information Journal ◽

10.1177/009286159703100409 ◽

1997 ◽

Vol 31 (4) ◽

pp. 1109-1125 ◽

Cited By ~ 1

Author(s):

Sang Guo-Wei

Keyword(s):

Clinical Trials ◽

Current Status

Download Full-text

Minimally Invasive Therapies for Female Stress Urinary Incontinence: the Current Status of Bioinjectables/New Devices (Adjustable Continence Therapy, Urethral Submucosal Collagen Denaturation by Radiofrequency)

The Scientific World JOURNAL ◽

10.1100/tsw.2009.53 ◽

2009 ◽

Vol 9 ◽

pp. 466-478 ◽

Cited By ~ 10

Author(s):

Simone Crivellaro ◽

John J. Smith

Keyword(s):

Clinical Trials ◽

Urinary Incontinence ◽

Clinical Practice ◽

Stress Urinary Incontinence ◽

Minimally Invasive ◽

Emerging Technologies ◽

Current Status ◽

Female Stress Urinary Incontinence ◽

Salvage Procedure ◽

Collagen Denaturation

The aim of this review is to provide an update on the current status of evolving minimally invasive therapies for stress urinary incontinence. Bioinjectables have been available for some time and their current status is reviewed. The adjustable continence device has been used as a salvage procedure for females for a number of years in clinical trials, yet many are unfamiliar with it. Lastly, radiofrequency via a transurethral route has also been utilized in small numbers and will be updated. These later two emerging technologies need further exposure to better define their role in our clinical practice.

Download Full-text